ID   NMNA3_HUMAN             Reviewed;         252 AA.
AC   Q96T66; B3KVR6; D3DNF2; D3DNF3; Q8N4G1;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   15-MAR-2017, entry version 130.
DE   RecName: Full=Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 {ECO:0000305};
DE            Short=NMN/NaMN adenylyltransferase 3;
DE   AltName: Full=Nicotinamide-nucleotide adenylyltransferase 3;
DE            Short=NMN adenylyltransferase 3;
DE   AltName: Full=Nicotinate-nucleotide adenylyltransferase 3;
DE            Short=NaMN adenylyltransferase 3;
DE            EC=2.7.7.18;
DE   AltName: Full=Pyridine nucleotide adenylyltransferase 3;
DE            Short=PNAT-3;
DE            EC=2.7.7.1;
GN   Name=NMNAT3; ORFNames=FKSG76;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wang Y.-G., Gong L.;
RT   "Identification of FKSG76, a novel gene encoding a NMN
RT   adenylyltransferase.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16118205; DOI=10.1074/jbc.M508660200;
RA   Berger F., Lau C., Dahlmann M., Ziegler M.;
RT   "Subcellular compartmentation and differential catalytic properties of
RT   the three human nicotinamide mononucleotide adenylyltransferase
RT   isoforms.";
RL   J. Biol. Chem. 280:36334-36341(2005).
RN   [7]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, AND
RP   COFACTOR.
RX   PubMed=17402747; DOI=10.1021/bi6023379;
RA   Sorci L., Cimadamore F., Scotti S., Petrelli R., Cappellacci L.,
RA   Franchetti P., Orsomando G., Magni G.;
RT   "Initial-rate kinetics of human NMN-adenylyltransferases: substrate
RT   and metal ion specificity, inhibition by products and multisubstrate
RT   analogues, and isozyme contributions to NAD+ biosynthesis.";
RL   Biochemistry 46:4912-4922(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH NMN; NAD AND ATP
RP   ANALOG, SUBCELLULAR LOCATION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=12574164; DOI=10.1074/jbc.M300073200;
RA   Zhang X., Kurnasov O.V., Karthikeyan S., Grishin N.V., Osterman A.L.,
RA   Zhang H.;
RT   "Structural characterization of a human cytosolic NMN/NaMN
RT   adenylyltransferase and implication in human NAD biosynthesis.";
RL   J. Biol. Chem. 278:13503-13511(2003).
CC   -!- FUNCTION: Catalyzes the formation of NAD(+) from nicotinamide
CC       mononucleotide (NMN) and ATP. Can also use the deamidated form;
CC       nicotinic acid mononucleotide (NaMN) as substrate with the same
CC       efficiency. Can use triazofurin monophosphate (TrMP) as substrate.
CC       Can also use GTP and ITP as nucleotide donors. Also catalyzes the
CC       reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD(+).
CC       For the pyrophosphorolytic activity, can use NAD(+), NADH, NaAD,
CC       nicotinic acid adenine dinucleotide phosphate (NHD), nicotinamide
CC       guanine dinucleotide (NGD) as substrates. Fails to cleave
CC       phosphorylated dinucleotides NADP(+), NADPH and NaADP(+). Protects
CC       against axonal degeneration following injury.
CC       {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}.
CC   -!- CATALYTIC ACTIVITY: ATP + nicotinamide ribonucleotide =
CC       diphosphate + NAD(+).
CC   -!- CATALYTIC ACTIVITY: ATP + beta-nicotinate-D-ribonucleotide =
CC       diphosphate + deamido-NAD(+).
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:17402747};
CC       Note=Divalent metal cations. Mg(2+) confers the highest activity.
CC       {ECO:0000269|PubMed:17402747};
CC   -!- ENZYME REGULATION: Activity is strongly inhibited by galotannin.
CC       Inhibited by P1-(adenosine-5')-P4-(nicotinic-acid-riboside-5')-
CC       tetraphosphate (Nap4AD). {ECO:0000269|PubMed:17402747}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=209 uM for NMN {ECO:0000269|PubMed:16118205,
CC         ECO:0000269|PubMed:17402747};
CC         KM=130 uM for NAD(+) {ECO:0000269|PubMed:16118205,
CC         ECO:0000269|PubMed:17402747};
CC         KM=29 uM for ATP {ECO:0000269|PubMed:16118205,
CC         ECO:0000269|PubMed:17402747};
CC         KM=390 uM for PPi {ECO:0000269|PubMed:16118205,
CC         ECO:0000269|PubMed:17402747};
CC         KM=276 uM for GTP {ECO:0000269|PubMed:16118205,
CC         ECO:0000269|PubMed:17402747};
CC         KM=350 uM for ITP {ECO:0000269|PubMed:16118205,
CC         ECO:0000269|PubMed:17402747};
CC         KM=111 uM for NaMN {ECO:0000269|PubMed:16118205,
CC         ECO:0000269|PubMed:17402747};
CC         KM=130 uM for NMNH {ECO:0000269|PubMed:16118205,
CC         ECO:0000269|PubMed:17402747};
CC         KM=2.01 uM for triazofurin monophosphate
CC         {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747};
CC         Vmax=3.6 umol/min/mg enzyme for NAD synthesis
CC         {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747};
CC         Vmax=12.8 umol/min/mg enzyme for pyrophosphorolytic NAD(+)
CC         cleavage {ECO:0000269|PubMed:16118205,
CC         ECO:0000269|PubMed:17402747};
CC         Vmax=2.9 umol/min/mg enzyme for pyrophosphorolytic NADH cleavage
CC         {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747};
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from
CC       nicotinamide D-ribonucleotide: step 1/1.
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; deamido-
CC       NAD(+) from nicotinate D-ribonucleotide: step 1/1.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:12574164}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:12574164,
CC       ECO:0000269|PubMed:16118205}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96T66-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96T66-2; Sequence=VSP_010267;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q96T66-3; Sequence=VSP_043203;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in lung and spleen with lower levels
CC       in placenta and kidney. {ECO:0000269|PubMed:12574164,
CC       ECO:0000269|PubMed:16118205}.
CC   -!- SIMILARITY: Belongs to the eukaryotic NMN adenylyltransferase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF345564; AAK52726.1; -; mRNA.
DR   EMBL; AK123208; BAG53878.1; -; mRNA.
DR   EMBL; AC046134; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110716; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79023.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79024.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79025.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79030.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79031.1; -; Genomic_DNA.
DR   EMBL; BC034374; AAH34374.1; -; mRNA.
DR   CCDS; CCDS3111.1; -. [Q96T66-2]
DR   CCDS; CCDS56282.1; -. [Q96T66-3]
DR   CCDS; CCDS82846.1; -. [Q96T66-1]
DR   RefSeq; NP_001186976.1; NM_001200047.2. [Q96T66-3]
DR   RefSeq; NP_001307440.1; NM_001320511.1. [Q96T66-1]
DR   RefSeq; NP_001307441.1; NM_001320512.1. [Q96T66-1]
DR   RefSeq; NP_835471.1; NM_178177.4. [Q96T66-2]
DR   RefSeq; XP_011511092.1; XM_011512790.1. [Q96T66-2]
DR   RefSeq; XP_011511093.1; XM_011512791.2. [Q96T66-2]
DR   RefSeq; XP_016861824.1; XM_017006335.1. [Q96T66-1]
DR   RefSeq; XP_016861825.1; XM_017006336.1. [Q96T66-1]
DR   RefSeq; XP_016861826.1; XM_017006337.1. [Q96T66-1]
DR   RefSeq; XP_016861827.1; XM_017006338.1. [Q96T66-2]
DR   UniGene; Hs.208673; -.
DR   UniGene; Hs.745268; -.
DR   PDB; 1NUP; X-ray; 1.90 A; A/B=1-252.
DR   PDB; 1NUQ; X-ray; 1.90 A; A/B=1-252.
DR   PDB; 1NUR; X-ray; 2.15 A; A/B=1-252.
DR   PDB; 1NUS; X-ray; 2.20 A; A/B=1-252.
DR   PDB; 1NUT; X-ray; 1.90 A; A/B=1-252.
DR   PDB; 1NUU; X-ray; 1.90 A; A/B=1-252.
DR   PDBsum; 1NUP; -.
DR   PDBsum; 1NUQ; -.
DR   PDBsum; 1NUR; -.
DR   PDBsum; 1NUS; -.
DR   PDBsum; 1NUT; -.
DR   PDBsum; 1NUU; -.
DR   ProteinModelPortal; Q96T66; -.
DR   SMR; Q96T66; -.
DR   BioGrid; 131564; 4.
DR   STRING; 9606.ENSP00000340523; -.
DR   DrugBank; DB04099; Deamido-Nad+.
DR   DrugBank; DB03227; Nicotinamide Mononucleotide.
DR   iPTMnet; Q96T66; -.
DR   PhosphoSitePlus; Q96T66; -.
DR   DMDM; 116242680; -.
DR   EPD; Q96T66; -.
DR   MaxQB; Q96T66; -.
DR   PaxDb; Q96T66; -.
DR   PeptideAtlas; Q96T66; -.
DR   PRIDE; Q96T66; -.
DR   DNASU; 349565; -.
DR   Ensembl; ENST00000296202; ENSP00000296202; ENSG00000163864. [Q96T66-1]
DR   Ensembl; ENST00000339837; ENSP00000340523; ENSG00000163864. [Q96T66-2]
DR   Ensembl; ENST00000413939; ENSP00000412953; ENSG00000163864. [Q96T66-3]
DR   GeneID; 349565; -.
DR   KEGG; hsa:349565; -.
DR   UCSC; uc003etj.4; human. [Q96T66-1]
DR   CTD; 349565; -.
DR   DisGeNET; 349565; -.
DR   GeneCards; NMNAT3; -.
DR   HGNC; HGNC:20989; NMNAT3.
DR   HPA; HPA039077; -.
DR   HPA; HPA057402; -.
DR   MIM; 608702; gene.
DR   neXtProt; NX_Q96T66; -.
DR   OpenTargets; ENSG00000163864; -.
DR   PharmGKB; PA134952303; -.
DR   eggNOG; KOG3199; Eukaryota.
DR   eggNOG; COG1057; LUCA.
DR   GeneTree; ENSGT00530000063189; -.
DR   HOGENOM; HOG000216047; -.
DR   HOVERGEN; HBG052640; -.
DR   InParanoid; Q96T66; -.
DR   KO; K06210; -.
DR   OMA; GMYQVIQ; -.
DR   OrthoDB; EOG091G0JTI; -.
DR   PhylomeDB; Q96T66; -.
DR   TreeFam; TF315035; -.
DR   BioCyc; MetaCyc:HS08953-MONOMER; -.
DR   BRENDA; 2.7.7.1; 2681.
DR   BRENDA; 2.7.7.18; 2681.
DR   Reactome; R-HSA-196807; Nicotinate metabolism.
DR   SABIO-RK; Q96T66; -.
DR   UniPathway; UPA00253; UER00332.
DR   UniPathway; UPA00253; UER00600.
DR   ChiTaRS; NMNAT3; human.
DR   EvolutionaryTrace; Q96T66; -.
DR   GenomeRNAi; 349565; -.
DR   PRO; PR:Q96T66; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163864; -.
DR   CleanEx; HS_NMNAT3; -.
DR   ExpressionAtlas; Q96T66; baseline and differential.
DR   Genevisible; Q96T66; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000309; F:nicotinamide-nucleotide adenylyltransferase activity; IBA:GO_Central.
DR   GO; GO:0004515; F:nicotinate-nucleotide adenylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0034628; P:'de novo' NAD biosynthetic process from aspartate; IBA:GO_Central.
DR   GO; GO:0009435; P:NAD biosynthetic process; IC:UniProtKB.
DR   GO; GO:0019674; P:NAD metabolic process; TAS:Reactome.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR004821; Cyt_trans-like.
DR   InterPro; IPR005248; NadD/NMNAT.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF01467; CTP_transf_like; 1.
DR   TIGRFAMs; TIGR00482; TIGR00482; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Magnesium; Mitochondrion; NAD; Nucleotide-binding;
KW   Nucleotidyltransferase; Pyridine nucleotide biosynthesis;
KW   Reference proteome; Transferase.
FT   CHAIN         1    252       Nicotinamide/nicotinic acid
FT                                mononucleotide adenylyltransferase 3.
FT                                /FTId=PRO_0000135016.
FT   NP_BIND      13     15       ATP. {ECO:0000269|PubMed:12574164}.
FT   NP_BIND     135    137       ATP. {ECO:0000269|PubMed:12574164}.
FT   NP_BIND     203    206       ATP. {ECO:0000269|PubMed:12574164}.
FT   REGION       53     55       Substrate binding.
FT                                {ECO:0000269|PubMed:12574164}.
FT   REGION       90     93       Substrate binding.
FT                                {ECO:0000269|PubMed:12574164}.
FT   REGION      147    148       Substrate binding.
FT                                {ECO:0000269|PubMed:12574164}.
FT   BINDING      22     22       ATP. {ECO:0000269|PubMed:12574164}.
FT   BINDING      56     56       ATP. {ECO:0000269|PubMed:12574164}.
FT   BINDING     140    140       ATP; shared with dimeric partner.
FT                                {ECO:0000269|PubMed:12574164}.
FT   VAR_SEQ       1     37       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010267.
FT   VAR_SEQ      37    125       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043203.
FT   CONFLICT    169    169       G -> S (in Ref. 1; AAK52726).
FT                                {ECO:0000305}.
FT   STRAND        5     13       {ECO:0000244|PDB:1NUP}.
FT   HELIX        20     35       {ECO:0000244|PDB:1NUP}.
FT   STRAND       37     48       {ECO:0000244|PDB:1NUP}.
FT   STRAND       54     56       {ECO:0000244|PDB:1NUP}.
FT   HELIX        61     71       {ECO:0000244|PDB:1NUP}.
FT   HELIX        72     74       {ECO:0000244|PDB:1NUP}.
FT   STRAND       76     80       {ECO:0000244|PDB:1NUP}.
FT   HELIX        83     86       {ECO:0000244|PDB:1NUP}.
FT   STRAND       87     89       {ECO:0000244|PDB:1NUP}.
FT   HELIX        93    104       {ECO:0000244|PDB:1NUP}.
FT   STRAND      129    135       {ECO:0000244|PDB:1NUP}.
FT   HELIX       136    141       {ECO:0000244|PDB:1NUP}.
FT   TURN        145    147       {ECO:0000244|PDB:1NUP}.
FT   HELIX       150    159       {ECO:0000244|PDB:1NUP}.
FT   STRAND      162    165       {ECO:0000244|PDB:1NUP}.
FT   HELIX       172    178       {ECO:0000244|PDB:1NUP}.
FT   HELIX       180    184       {ECO:0000244|PDB:1NUP}.
FT   HELIX       186    188       {ECO:0000244|PDB:1NUP}.
FT   STRAND      189    192       {ECO:0000244|PDB:1NUP}.
FT   HELIX       202    210       {ECO:0000244|PDB:1NUP}.
FT   HELIX       221    229       {ECO:0000244|PDB:1NUP}.
FT   TURN        230    233       {ECO:0000244|PDB:1NUQ}.
SQ   SEQUENCE   252 AA;  28322 MW;  6402CFB2FE789CF4 CRC64;
     MKSRIPVVLL ACGSFNPITN MHLRMFEVAR DHLHQTGMYQ VIQGIISPVN DTYGKKDLAA
     SHHRVAMARL ALQTSDWIRV DPWESEQAQW METVKVLRHH HSKLLRSPPQ MEGPDHGKAL
     FSTPAAVPEL KLLCGADVLK TFQTPNLWKD AHIQEIVEKF GLVCVGRVGH DPKGYIAESP
     ILRMHQHNIH LAKEPVQNEI SATYIRRALG QGQSVKYLIP DAVITYIKDH GLYTKGSTWK
     GKSTQSTEGK TS
//
